Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-03

Clinical Trial Update: Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating temporally-resolved electrophysiology of acamprosate for Alcohol Use Disorder; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Campral (acamprosate)

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcohol Use Disorder | Phase 4 | Status: RECRUITING